# Standard Versus Super-extended Lymphadenectomy After Neo-adjuvant Chemotherapy for Gastric Cancer

> **NCT03961373** · PHASE3 · RECRUITING · sponsor: **University of Siena** · enrollment: 539 (estimated)

## Conditions studied

- Locally Advanced Gastric Cancer

## Interventions

- **PROCEDURE:** Gastrectomy with D2 lymphadenectomy
- **PROCEDURE:** Gastrectomy with D2plus lymphadenectomy

## Key facts

- **NCT ID:** NCT03961373
- **Lead sponsor:** University of Siena
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-11-05
- **Primary completion:** 2023-11-01
- **Final completion:** 2028-11-01
- **Target enrollment:** 539 (ESTIMATED)
- **Last updated:** 2019-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03961373

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03961373, "Standard Versus Super-extended Lymphadenectomy After Neo-adjuvant Chemotherapy for Gastric Cancer". Retrieved via AI Analytics 2026-08-20 from https://api.ai-analytics.org/clinical/NCT03961373. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*